GlassScriptPhysician profile
Robert J Brunner
NPI 1003377730
$1,409.26
in general payments reported to CMS, 2019-2025
16 companies · $465 in 2025
The $465 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $662 · 2024: $282 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,409.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $582.27 | 2023-2024 | Rezum Generator, Lithovue, Ams 700 |
| Sumitomo Pharma America, INC. | $212.54 | 2024-2025 | Orgovyx, Gemtesa |
| Medtronic, INC. | $157.67 | 2023-2025 | Interstim, V-Loc 180 |
| Merck Sharp & Dohme LLC | $79.36 | 2024-2025 | Keytruda, Lynparza |
| Novartis Pharmaceuticals Corporation | $65.19 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $57.58 | 2025 | Provenge |
| Antares Pharma, INC. | $50.00 | 2023 | Xyosted, Tlando |
| Olympus America INC. | $45.66 | 2025 | Itind System |
| Laborie Medical Technologies Corp. | $24.44 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $22.25 | 2025 | |
| Azurity Pharmaceuticals, INC. | $21.55 | 2025 | Azmiro |
| Endo USA, INC. | $20.81 | 2025 | Aveed, Xiaflex |
| Tolmar, INC. | $20.16 | 2024 | |
| Fujifilm Healthcare Americas Corporation | $18.03 | 2023 | Arietta Precision |
| Procept Biorobotics Corporation | $17.11 | 2024 | Aquabeam System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $14.64 | 2025 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brunner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.